0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Solid Phase Synthesis Carrier for Peptide Drug Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-33Q19084
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Solid Phase Synthesis Carrier for Peptide Drug Market Research Report 2025
BUY CHAPTERS

Global Solid Phase Synthesis Carrier for Peptide Drug Market Research Report 2025

Code: QYRE-Auto-33Q19084
Report
March 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Solid Phase Synthesis Carrier for Peptide Drug Market Size

The global market for Solid Phase Synthesis Carrier for Peptide Drug was valued at US$ 123 million in the year 2024 and is projected to reach a revised size of US$ 232 million by 2031, growing at a CAGR of 9.6% during the forecast period.

Solid Phase Synthesis Carrier for Peptide Drug Market

Solid Phase Synthesis Carrier for Peptide Drug Market

Compared to liquid-phase synthesis, solid-phase synthesis offers significant advantages, especially in peptide drug production. The solid-phase synthesis carrier immobilizes the starting amino acid, eliminating the need for complex separation and purification steps, thereby greatly enhancing synthesis efficiency. Its ease of operation and repetitive coupling and deprotection steps make it well-suited for automated production, improving manufacturing efficiency and consistency. Furthermore, this method increases the yield and purity of the target product, meeting the growing demands of downstream customers and accelerating the research and industrialization of peptide drugs.
North American market for Solid Phase Synthesis Carrier for Peptide Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Solid Phase Synthesis Carrier for Peptide Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Solid Phase Synthesis Carrier for Peptide Drug include Sunresin, Tianjin Nankai Hecheng Science & Technology, Zhejiang Zhengguang, Jiangsu Haipu Functional Materials, RawPEG, Merck, CEM Corporation, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Solid Phase Synthesis Carrier for Peptide Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Phase Synthesis Carrier for Peptide Drug.
The Solid Phase Synthesis Carrier for Peptide Drug market size, estimations, and forecasts are provided in terms of output/shipments (kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid Phase Synthesis Carrier for Peptide Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Phase Synthesis Carrier for Peptide Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Solid Phase Synthesis Carrier for Peptide Drug Market Report

Report Metric Details
Report Name Solid Phase Synthesis Carrier for Peptide Drug Market
Accounted market size in year US$ 123 million
Forecasted market size in 2031 US$ 232 million
CAGR 9.6%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Hydroxyl Resins
  • Chloromethyl Resins
  • Amino Resins
  • Others
by Application
  • Tumors
  • Metabolic Diseases
  • Cardiovascular
  • Orthopedics
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sunresin, Tianjin Nankai Hecheng Science & Technology, Zhejiang Zhengguang, Jiangsu Haipu Functional Materials, RawPEG, Merck, CEM Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Solid Phase Synthesis Carrier for Peptide Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Solid Phase Synthesis Carrier for Peptide Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Solid Phase Synthesis Carrier for Peptide Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Solid Phase Synthesis Carrier for Peptide Drug Market growing?

Ans: The Solid Phase Synthesis Carrier for Peptide Drug Market witnessing a CAGR of 9.6% during the forecast period 2025-2031.

What is the Solid Phase Synthesis Carrier for Peptide Drug Market size in 2031?

Ans: The Solid Phase Synthesis Carrier for Peptide Drug Market size in 2031 will be US$ 232 million.

Who are the main players in the Solid Phase Synthesis Carrier for Peptide Drug Market report?

Ans: The main players in the Solid Phase Synthesis Carrier for Peptide Drug Market are Sunresin, Tianjin Nankai Hecheng Science & Technology, Zhejiang Zhengguang, Jiangsu Haipu Functional Materials, RawPEG, Merck, CEM Corporation

What are the Application segmentation covered in the Solid Phase Synthesis Carrier for Peptide Drug Market report?

Ans: The Applications covered in the Solid Phase Synthesis Carrier for Peptide Drug Market report are Tumors, Metabolic Diseases, Cardiovascular, Orthopedics, Others

What are the Type segmentation covered in the Solid Phase Synthesis Carrier for Peptide Drug Market report?

Ans: The Types covered in the Solid Phase Synthesis Carrier for Peptide Drug Market report are Hydroxyl Resins, Chloromethyl Resins, Amino Resins, Others

1 Solid Phase Synthesis Carrier for Peptide Drug Market Overview
1.1 Product Definition
1.2 Solid Phase Synthesis Carrier for Peptide Drug by Type
1.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Hydroxyl Resins
1.2.3 Chloromethyl Resins
1.2.4 Amino Resins
1.2.5 Others
1.3 Solid Phase Synthesis Carrier for Peptide Drug by Application
1.3.1 Global Solid Phase Synthesis Carrier for Peptide Drug Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tumors
1.3.3 Metabolic Diseases
1.3.4 Cardiovascular
1.3.5 Orthopedics
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Estimates and Forecasts (2020-2031)
1.4.4 Global Solid Phase Synthesis Carrier for Peptide Drug Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Manufacturers (2020-2025)
2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Solid Phase Synthesis Carrier for Peptide Drug, Industry Ranking, 2023 VS 2024
2.4 Global Solid Phase Synthesis Carrier for Peptide Drug Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Solid Phase Synthesis Carrier for Peptide Drug Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Product Offered and Application
2.8 Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Date of Enter into This Industry
2.9 Solid Phase Synthesis Carrier for Peptide Drug Market Competitive Situation and Trends
2.9.1 Solid Phase Synthesis Carrier for Peptide Drug Market Concentration Rate
2.9.2 Global 5 and 10 Largest Solid Phase Synthesis Carrier for Peptide Drug Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Solid Phase Synthesis Carrier for Peptide Drug Production by Region
3.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Region (2020-2031)
3.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Solid Phase Synthesis Carrier for Peptide Drug by Region (2026-2031)
3.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Solid Phase Synthesis Carrier for Peptide Drug Production Volume by Region (2020-2031)
3.4.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Solid Phase Synthesis Carrier for Peptide Drug by Region (2026-2031)
3.5 Global Solid Phase Synthesis Carrier for Peptide Drug Market Price Analysis by Region (2020-2025)
3.6 Global Solid Phase Synthesis Carrier for Peptide Drug Production and Value, Year-over-Year Growth
3.6.1 North America Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Solid Phase Synthesis Carrier for Peptide Drug Production Value Estimates and Forecasts (2020-2031)
4 Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region
4.1 Global Solid Phase Synthesis Carrier for Peptide Drug Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2031)
4.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2025)
4.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Type (2020-2031)
5.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Type (2020-2025)
5.1.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Type (2026-2031)
5.1.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Type (2020-2031)
5.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Type (2020-2031)
5.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Type (2020-2025)
5.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Type (2026-2031)
5.2.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Type (2020-2031)
5.3 Global Solid Phase Synthesis Carrier for Peptide Drug Price by Type (2020-2031)
6 Segment by Application
6.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Application (2020-2031)
6.1.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Application (2020-2025)
6.1.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production by Application (2026-2031)
6.1.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Application (2020-2031)
6.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Application (2020-2031)
6.2.1 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Application (2020-2025)
6.2.2 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Application (2026-2031)
6.2.3 Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Application (2020-2031)
6.3 Global Solid Phase Synthesis Carrier for Peptide Drug Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Sunresin
7.1.1 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.1.2 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.1.3 Sunresin Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Sunresin Main Business and Markets Served
7.1.5 Sunresin Recent Developments/Updates
7.2 Tianjin Nankai Hecheng Science & Technology
7.2.1 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.2.2 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.2.3 Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Tianjin Nankai Hecheng Science & Technology Main Business and Markets Served
7.2.5 Tianjin Nankai Hecheng Science & Technology Recent Developments/Updates
7.3 Zhejiang Zhengguang
7.3.1 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.3.2 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.3.3 Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Zhejiang Zhengguang Main Business and Markets Served
7.3.5 Zhejiang Zhengguang Recent Developments/Updates
7.4 Jiangsu Haipu Functional Materials
7.4.1 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.4.2 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.4.3 Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jiangsu Haipu Functional Materials Main Business and Markets Served
7.4.5 Jiangsu Haipu Functional Materials Recent Developments/Updates
7.5 RawPEG
7.5.1 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.5.2 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.5.3 RawPEG Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.5.4 RawPEG Main Business and Markets Served
7.5.5 RawPEG Recent Developments/Updates
7.6 Merck
7.6.1 Merck Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.6.2 Merck Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.6.3 Merck Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Merck Main Business and Markets Served
7.6.5 Merck Recent Developments/Updates
7.7 CEM Corporation
7.7.1 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Company Information
7.7.2 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Product Portfolio
7.7.3 CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Production, Value, Price and Gross Margin (2020-2025)
7.7.4 CEM Corporation Main Business and Markets Served
7.7.5 CEM Corporation Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Solid Phase Synthesis Carrier for Peptide Drug Industry Chain Analysis
8.2 Solid Phase Synthesis Carrier for Peptide Drug Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Solid Phase Synthesis Carrier for Peptide Drug Production Mode & Process Analysis
8.4 Solid Phase Synthesis Carrier for Peptide Drug Sales and Marketing
8.4.1 Solid Phase Synthesis Carrier for Peptide Drug Sales Channels
8.4.2 Solid Phase Synthesis Carrier for Peptide Drug Distributors
8.5 Solid Phase Synthesis Carrier for Peptide Drug Customer Analysis
9 Solid Phase Synthesis Carrier for Peptide Drug Market Dynamics
9.1 Solid Phase Synthesis Carrier for Peptide Drug Industry Trends
9.2 Solid Phase Synthesis Carrier for Peptide Drug Market Drivers
9.3 Solid Phase Synthesis Carrier for Peptide Drug Market Challenges
9.4 Solid Phase Synthesis Carrier for Peptide Drug Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Solid Phase Synthesis Carrier for Peptide Drug Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Solid Phase Synthesis Carrier for Peptide Drug Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Solid Phase Synthesis Carrier for Peptide Drug Production Capacity (kg) by Manufacturers in 2024
 Table 4. Global Solid Phase Synthesis Carrier for Peptide Drug Production by Manufacturers (2020-2025) & (kg)
 Table 5. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Solid Phase Synthesis Carrier for Peptide Drug, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Solid Phase Synthesis Carrier for Peptide Drug as of 2024)
 Table 10. Global Market Solid Phase Synthesis Carrier for Peptide Drug Average Price by Manufacturers (US$/g) & (2020-2025)
 Table 11. Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Product Offered and Application
 Table 13. Global Key Manufacturers of Solid Phase Synthesis Carrier for Peptide Drug, Date of Enter into This Industry
 Table 14. Global Solid Phase Synthesis Carrier for Peptide Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Region (2020-2025)
 Table 19. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Solid Phase Synthesis Carrier for Peptide Drug Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
 Table 22. Global Solid Phase Synthesis Carrier for Peptide Drug Production (kg) by Region (2020-2025)
 Table 23. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Region (2020-2025)
 Table 24. Global Solid Phase Synthesis Carrier for Peptide Drug Production (kg) Forecast by Region (2026-2031)
 Table 25. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Solid Phase Synthesis Carrier for Peptide Drug Market Average Price (US$/g) by Region (2020-2025)
 Table 27. Global Solid Phase Synthesis Carrier for Peptide Drug Market Average Price (US$/g) by Region (2026-2031)
 Table 28. Global Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)
 Table 29. Global Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2025) & (kg)
 Table 30. Global Solid Phase Synthesis Carrier for Peptide Drug Consumption Market Share by Region (2020-2025)
 Table 31. Global Solid Phase Synthesis Carrier for Peptide Drug Forecasted Consumption by Region (2026-2031) & (kg)
 Table 32. Global Solid Phase Synthesis Carrier for Peptide Drug Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 34. North America Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2025) & (kg)
 Table 35. North America Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2026-2031) & (kg)
 Table 36. Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 37. Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2025) & (kg)
 Table 38. Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2026-2031) & (kg)
 Table 39. Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (kg)
 Table 40. Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2020-2025) & (kg)
 Table 41. Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region (2026-2031) & (kg)
 Table 42. Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (kg)
 Table 43. Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2020-2025) & (kg)
 Table 44. Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption by Country (2026-2031) & (kg)
 Table 45. Global Solid Phase Synthesis Carrier for Peptide Drug Production (kg) by Type (2020-2025)
 Table 46. Global Solid Phase Synthesis Carrier for Peptide Drug Production (kg) by Type (2026-2031)
 Table 47. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Type (2020-2025)
 Table 48. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Type (2026-2031)
 Table 49. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Type (2020-2025)
 Table 52. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Type (2026-2031)
 Table 53. Global Solid Phase Synthesis Carrier for Peptide Drug Price (US$/g) by Type (2020-2025)
 Table 54. Global Solid Phase Synthesis Carrier for Peptide Drug Price (US$/g) by Type (2026-2031)
 Table 55. Global Solid Phase Synthesis Carrier for Peptide Drug Production (kg) by Application (2020-2025)
 Table 56. Global Solid Phase Synthesis Carrier for Peptide Drug Production (kg) by Application (2026-2031)
 Table 57. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Application (2020-2025)
 Table 58. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Application (2026-2031)
 Table 59. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Application (2020-2025)
 Table 62. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Application (2026-2031)
 Table 63. Global Solid Phase Synthesis Carrier for Peptide Drug Price (US$/g) by Application (2020-2025)
 Table 64. Global Solid Phase Synthesis Carrier for Peptide Drug Price (US$/g) by Application (2026-2031)
 Table 65. Sunresin Solid Phase Synthesis Carrier for Peptide Drug Company Information
 Table 66. Sunresin Solid Phase Synthesis Carrier for Peptide Drug Specification and Application
 Table 67. Sunresin Solid Phase Synthesis Carrier for Peptide Drug Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 68. Sunresin Main Business and Markets Served
 Table 69. Sunresin Recent Developments/Updates
 Table 70. Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Company Information
 Table 71. Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Specification and Application
 Table 72. Tianjin Nankai Hecheng Science & Technology Solid Phase Synthesis Carrier for Peptide Drug Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 73. Tianjin Nankai Hecheng Science & Technology Main Business and Markets Served
 Table 74. Tianjin Nankai Hecheng Science & Technology Recent Developments/Updates
 Table 75. Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Company Information
 Table 76. Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Specification and Application
 Table 77. Zhejiang Zhengguang Solid Phase Synthesis Carrier for Peptide Drug Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 78. Zhejiang Zhengguang Main Business and Markets Served
 Table 79. Zhejiang Zhengguang Recent Developments/Updates
 Table 80. Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Company Information
 Table 81. Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Specification and Application
 Table 82. Jiangsu Haipu Functional Materials Solid Phase Synthesis Carrier for Peptide Drug Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 83. Jiangsu Haipu Functional Materials Main Business and Markets Served
 Table 84. Jiangsu Haipu Functional Materials Recent Developments/Updates
 Table 85. RawPEG Solid Phase Synthesis Carrier for Peptide Drug Company Information
 Table 86. RawPEG Solid Phase Synthesis Carrier for Peptide Drug Specification and Application
 Table 87. RawPEG Solid Phase Synthesis Carrier for Peptide Drug Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 88. RawPEG Main Business and Markets Served
 Table 89. RawPEG Recent Developments/Updates
 Table 90. Merck Solid Phase Synthesis Carrier for Peptide Drug Company Information
 Table 91. Merck Solid Phase Synthesis Carrier for Peptide Drug Specification and Application
 Table 92. Merck Solid Phase Synthesis Carrier for Peptide Drug Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 93. Merck Main Business and Markets Served
 Table 94. Merck Recent Developments/Updates
 Table 95. CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Company Information
 Table 96. CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Specification and Application
 Table 97. CEM Corporation Solid Phase Synthesis Carrier for Peptide Drug Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 98. CEM Corporation Main Business and Markets Served
 Table 99. CEM Corporation Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Solid Phase Synthesis Carrier for Peptide Drug Distributors List
 Table 103. Solid Phase Synthesis Carrier for Peptide Drug Customers List
 Table 104. Solid Phase Synthesis Carrier for Peptide Drug Market Trends
 Table 105. Solid Phase Synthesis Carrier for Peptide Drug Market Drivers
 Table 106. Solid Phase Synthesis Carrier for Peptide Drug Market Challenges
 Table 107. Solid Phase Synthesis Carrier for Peptide Drug Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Solid Phase Synthesis Carrier for Peptide Drug
 Figure 2. Global Solid Phase Synthesis Carrier for Peptide Drug Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Solid Phase Synthesis Carrier for Peptide Drug Market Share by Type: 2024 VS 2031
 Figure 4. Hydroxyl Resins Product Picture
 Figure 5. Chloromethyl Resins Product Picture
 Figure 6. Amino Resins Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Solid Phase Synthesis Carrier for Peptide Drug Market Value by Application, (US$ Million) & (2020-2031)
 Figure 9. Global Solid Phase Synthesis Carrier for Peptide Drug Market Share by Application: 2024 VS 2031
 Figure 10. Tumors
 Figure 11. Metabolic Diseases
 Figure 12. Cardiovascular
 Figure 13. Orthopedics
 Figure 14. Others
 Figure 15. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) & (2020-2031)
 Figure 17. Global Solid Phase Synthesis Carrier for Peptide Drug Production Capacity (kg) & (2020-2031)
 Figure 18. Global Solid Phase Synthesis Carrier for Peptide Drug Production (kg) & (2020-2031)
 Figure 19. Global Solid Phase Synthesis Carrier for Peptide Drug Average Price (US$/g) & (2020-2031)
 Figure 20. Solid Phase Synthesis Carrier for Peptide Drug Report Years Considered
 Figure 21. Solid Phase Synthesis Carrier for Peptide Drug Production Share by Manufacturers in 2024
 Figure 22. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Share by Manufacturers (2024)
 Figure 23. Solid Phase Synthesis Carrier for Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. The Global 5 and 10 Largest Players: Market Share by Solid Phase Synthesis Carrier for Peptide Drug Revenue in 2024
 Figure 25. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 26. Global Solid Phase Synthesis Carrier for Peptide Drug Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 27. Global Solid Phase Synthesis Carrier for Peptide Drug Production Comparison by Region: 2020 VS 2024 VS 2031 (kg)
 Figure 28. Global Solid Phase Synthesis Carrier for Peptide Drug Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 29. North America Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Europe Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 31. China Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. Japan Solid Phase Synthesis Carrier for Peptide Drug Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 33. Global Solid Phase Synthesis Carrier for Peptide Drug Consumption by Region: 2020 VS 2024 VS 2031 (kg)
 Figure 34. Global Solid Phase Synthesis Carrier for Peptide Drug Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 35. North America Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 36. North America Solid Phase Synthesis Carrier for Peptide Drug Consumption Market Share by Country (2020-2031)
 Figure 37. U.S. Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 38. Canada Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 39. Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 40. Europe Solid Phase Synthesis Carrier for Peptide Drug Consumption Market Share by Country (2020-2031)
 Figure 41. Germany Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 42. France Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 43. U.K. Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 44. Italy Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 45. Russia Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 46. Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 47. Asia Pacific Solid Phase Synthesis Carrier for Peptide Drug Consumption Market Share by Region (2020-2031)
 Figure 48. China Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 49. Japan Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 50. South Korea Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 51. China Taiwan Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 52. Southeast Asia Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 53. India Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 54. Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 55. Latin America, Middle East & Africa Solid Phase Synthesis Carrier for Peptide Drug Consumption Market Share by Country (2020-2031)
 Figure 56. Mexico Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 57. Brazil Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 58. Turkey Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 59. GCC Countries Solid Phase Synthesis Carrier for Peptide Drug Consumption and Growth Rate (2020-2031) & (kg)
 Figure 60. Global Production Market Share of Solid Phase Synthesis Carrier for Peptide Drug by Type (2020-2031)
 Figure 61. Global Production Value Market Share of Solid Phase Synthesis Carrier for Peptide Drug by Type (2020-2031)
 Figure 62. Global Solid Phase Synthesis Carrier for Peptide Drug Price (US$/g) by Type (2020-2031)
 Figure 63. Global Production Market Share of Solid Phase Synthesis Carrier for Peptide Drug by Application (2020-2031)
 Figure 64. Global Production Value Market Share of Solid Phase Synthesis Carrier for Peptide Drug by Application (2020-2031)
 Figure 65. Global Solid Phase Synthesis Carrier for Peptide Drug Price (US$/g) by Application (2020-2031)
 Figure 66. Solid Phase Synthesis Carrier for Peptide Drug Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS